SLRN - ACELYRIN, Inc.

QQQ $ 604.48 $ 6.27 (1.05 %)

DIA $ 462.18 $ 2.39 (0.52 %)

SPY $ 664.96 $ 4.85 (0.74 %)

TLT $ 91.04 $ -0.05 (-0.05 %)

GLD $ 389.87 $ -8.41 (-2.12 %)

Previous Close

$ 2.27

Open

Bid

-- x --

Ask

-- x --

Day's Range

-- - --

52 Week Range

$ 1.85 - $ 7.25

Volume

4,076,542

Average Volume

Market Cap

229.16M

Beta (5Y Monthly)

$ 0.88

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	05-14-2025	03-31-2025	10-Q
2	03-19-2025	12-31-2024	10-K
3	11-13-2024	09-30-2024	10-Q
4	08-13-2024	06-30-2024	10-Q
5	05-14-2024	03-31-2024	10-Q
6	03-28-2024	12-31-2023	10-K
7	11-09-2023	09-30-2023	10-Q
8	08-14-2023	06-30-2023	10-Q
9	06-15-2023	03-31-2023	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

ACELYRIN Stockholders Approve Merger With ...
05/13/2025 17:07:40

ACELYRIN, Inc. (NASDAQ:SLRN), a late-stage clinical biopharma company focused on accelerating the development and delivery of t...

Lumis Stockholders Approve All Proposals R...
05/13/2025 17:03:00

lumis Inc. (NASDAQ:ALMS), a clinical-stage biopharmaceutical company developing therapies using a precision approach to optimiz...

Alumis And ACELYRIN Finalize Amended Merge...
04/21/2025 10:33:16

ACELYRIN stockholders to receive increased ownership in the combined company through revised exchange ratio; Alumis and ACELYRI...

Alumis and ACELYRIN File Joint Definitive ...
04/04/2025 20:37:23

ACELYRIN Implements Stockholder Rights Pla...
03/13/2025 11:18:10

ACELYRIN Board Determined The Unsolicited ...
03/04/2025 14:03:24

Reported Earlier, ACELYRIN Confirms Unsoli...
02/21/2025 06:18:21

ACELYRIN confirmed receipt of an unsolicited indication of interest from Concentra Biosciences, LLC, of which Tang Capital Part...

Alumis and ACELYRIN To Merge; ACELYRIN Sto...
02/06/2025 21:31:09

opline data from Phase 3 ONWARD trials for Alumis' ESK-001 in moderate-to-severe plaque psoriasis on track for readout in f...

Trading Halt: Halted at 4:13:29 p.m. ET - ...
02/06/2025 21:13:33

Citigroup Maintains Neutral on Acelyrin, L...
01/07/2025 19:58:24

Citigroup analyst Samantha Semenkow maintains Acelyrin (NASDAQ:SLRN) with a Neutral and lowers the price target from $6 to $3.

Nasdaq Down 1.5%; RPM Posts Upbeat Results
01/07/2025 17:05:55

dow-surges-over-100-points-us-trade-deficit-widens-in-november

Dow Surges Over 100 Points; US Trade Defic...
01/07/2025 15:00:44

acelyrin-tesla-and-other-big-stocks-moving-lower-in-tuesdays-pre-market-session

Acelyrin, Tesla And Other Big Stocks Movin...
01/07/2025 13:42:11

why-inari-medical-shares-are-trading-higher-by-21-here-are-20-stocks-moving-premarket

Why Inari Medical Shares Are Trading Highe...
01/07/2025 12:15:03

Market-Moving News for January 7th
01/07/2025 12:12:14

ULTA: 4.8% | Ulta Beauty shares are trading higher after the company issued Q4 expectations for modest comparable sales growth ...

HC Wainwright & Co. Maintains Neutral on A...
01/07/2025 11:24:12

HC Wainwright & Co. analyst Emily Bodnar maintains Acelyrin (NASDAQ:SLRN) with a Neutral and lowers the price target fro...

ACELYRIN Announces Additional Phase 2 Data...
01/06/2025 21:00:57

Totality of data observed with subcutaneous lonigutamab in Thyroid Eye Disease (TED) patients demonstrate potential for efficac...

What's Going On With ACELYRIN Shares Friday?
01/03/2025 18:52:46

ACELYRIN shares are moving higher on Friday after the company announced that it will reveal Phase 2 data and announce Phase 3 p...

rivian-automotive-cerence-nu-skin-enterprises-and-other-big-stocks-moving-higher-on-friday

Rivian Automotive, Cerence, Nu Skin Enterp...
01/03/2025 15:22:18

Reported Earlier, Acelyrin To Reveal New P...
01/03/2025 06:08:18